Prestige Biopharma shareholders adopt resolution to reappoint independent director Bang Gyu-ho

PUBT · 4d ago
Prestige Biopharma shareholders adopt resolution to reappoint independent director Bang Gyu-ho
  • Prestige Biopharma held its annual shareholders’ meeting on 2026-09-29.
  • Shareholders received the fiscal year financial statements, covering consolidated and separate results, with unqualified audit opinions for both.
  • A resolution to reappoint independent director Kyooho Bang as an audit committee member was adopted.
  • Resolutions to delegate authority to the board to appoint Nexia Samduk as auditor, set audit fees, and approve share issuances were adopted.
  • Resolutions authorize future actions; the filing did not confirm any related share issuance or auditor appointment had been executed.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prestige Biopharma Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260929800648), on September 29, 2026, and is solely responsible for the information contained therein.